 Home > Active Ingredient News > Immunology News > Novar3 IL-17A monoantigen Cosentyx: Approved by the European Union for first-line treatment of psoriasis children.

Novar3 IL-17A monoantigen Cosentyx: Approved by the European Union for first-line treatment of psoriasis children.

 Last Update: 2020-10-03
 Source: Internet
 Author: User

Tags

3 5 strength

days 100 years

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Novarma's leumelocyte-17A (IL-17A) monoantigen Cosentyx (secukinumab) has been approved by the European Commission for the treatment of children and adolescents aged 6-18 with severe plaque-like psoriasis.
: The approval is based on two Phase 3 studies of children and adolescents aged 6-18 years.
in two studies, both low-dose (75-150 mg) and high-dose (75-300 mg) Cosentyx were able to rapidly improve skin symptoms and quality of life in patients.
low dose of Cosentyx can quickly remove skin, with 93% of children reaching Psoriasis Regional Severity Index (PASI) at week 12, 69% reaching PASI 90 in week 12 and PASI 90 at week 24.
addition, 59.5 per cent of children received fully transparent skin (PASI 100) at week 12 and 67 per cent achieved PASI 100 at week 24.
For patients with severe psoriasis, low doses of Consentyx help maintain skin cleanliness up to 52 weeks, with 75% of patients achieving PASI 90 and 44.7% achieving complete remission at 12 weeks.
.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Purity 99% BPN14770 Zatolmilast 1606974-33-7 In Stock Fast Ship to USA

CAS No.: 1606974-33-7

Pharm Grade

$1-1.1/UNIT FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.